| DDI HV (ATV - Merck) (NCT00518297) | Bristol-Myers Squibb | 2007-08-01 |
| A Study of the PK, Safety and Antiviral Activity of A-831 in HCV Carriers (NCT00522808) | Arrow Therapeutics | 2007-08-01 |
| Dose Study in Healthy Males Investigating Safety, Pharmacokinetics and Pharmacodynamics of NNC126-0083 Compared to Norditropin® SimpleXx® (NCT01034202) | Novo Nordisk A/S | 2007-08-01 |
| Pandemic Influenza Plasmid DNA Vaccines (Needle) (NCT00709800) | Vical | 2007-08-01 |
| MQX-503 vs Nitroglycerin Ointment: A Pharmacokinetic Comparison in Normal Subjects (NCT00513994) | MediQuest Therapeutics | 2007-08-01 |
| A Phase I Study of ABT-888 in Combination With Temozolomide in Cancer Patients (NCT00526617) | AbbVie | 2007-08-01 |
| Phase I Oral mTOR Inhibitor RAD001 in Combo w/ Capecitabine for Metastatic Breast (NCT00473005) | Stanford University | 2007-08-01 |
| Pharmacokinetics of Insulin Detemir in Healthy Chinese Male Subjects (NCT01498939) | Novo Nordisk A/S | 2007-08-01 |
| A Study to Quantify Bacille Calmette Guerin (BCG) and Characterise the Immune Response After BCG Vaccination (NCT00653627) | University of Oxford | 2007-08-01 |
| Study Evaluating Multiple Doses Of GSI-953 Within The Elderly Population (NCT00547560) | Wyeth is now a wholly owned subsidiary of Pfizer | 2007-08-01 |
| Outcomes in a Comparison of Manual Penetrating Keratoplasty and the IntraLase® Enabled Keratoplasty (NCT00566605) | Hospital Oftalmologico de Sorocaba | 2007-08-01 |
| A Randomized, Placebo-Controlled, Two-Period, Crossover Study to Evaluate the Effect of Lurasidone HCl on Oral Contraceptive Pharmacokinetics in Healthy Female Subjects (NCT00549666) | Sumitomo Pharma America, Inc. | 2007-08-01 |
| Energy Specific Far Infrared Radiation Treatment for Erectile Dysfunction (NCT00573209) | GAAD Medical Research Institute Inc. | 2007-08-01 |
| Clinical Assessment of GSK716155 for Type 2 Diabetes Mellitus (NCT00530309) | GlaxoSmithKline | 2007-08-01 |
| Unrelated Cord Blood Transplant Plus a Haplo-Identical (Half-Matched), T-Cell Depleted Stem Transplant From a Related Donor for Subjects With High Risk Malignancies (NCT00673114) | Joanne Kurtzberg, MD | 2007-08-01 |
| An Open-label, Single-center, Phase 1/ 2 Study of Chemoradiotherapy and AT-101 in Patients With Locally Advanced Esophageal or Gastroesophageal Junction Cancer (NCT00561197) | Ascenta Therapeutics | 2007-08-01 |
| A Single-Dose Pharmacokinetics and Safety Study of Ceftobiprole in Pediatric Patients =3 Months to <18 Years of Age (NCT01026636) | Basilea Pharmaceutica | 2007-08-01 |
| A Safety and Pharmacokinetic Study of TAK-285 in Patients With Advanced Cancer (NCT00535522) | Millennium Pharmaceuticals, Inc. | 2007-08-01 |
| Phase I/II Study of SOL for Untreated Metastatic Colorectal Cancer (NCT00524706) | Shizuoka Cancer Center | 2007-08-01 |
| Safety Study of Thermal Stimulation on Upper Extremity Motor Recovery to Stroke (NCT01078727) | Kaohsiung Medical University Chung-Ho Memorial Hospital | 2007-08-01 |
| A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Inhaled Montelukast (MK-0476) in Participants With Mild or Moderate Asthma (MK-0476-380 AM3)(COMPLETED) (NCT00636207) | Organon and Co | 2007-08-01 |
| Phase 1-2 Study of Deoxycholic Acid Injection (ATX-101) for the Reduction of Submental Fat (NCT00618722) | Kythera Biopharmaceuticals | 2007-08-01 |
| CyberSenga: Internet-based HIV Prevention in Uganda (NCT00906178) | Center for Innovative Public Health Research | 2007-08-01 |
| Phase 1/2 Study of VELCADE® in Combination With Other Drugs to Treat Previously Untreated Multiple Myeloma Patients (NCT00507442) | Millennium Pharmaceuticals, Inc. | 2007-08-01 |
| Evaluate the Migration Potential of Xeomin® Compared to Two Other Botulinum Toxin Type A Products (NCT00515944) | Merz Pharmaceuticals GmbH | 2007-08-01 |
| Azacitidine and Valproic Acid Plus Carboplatin in Patients With Ovarian Cancer (NCT00529022) | M.D. Anderson Cancer Center | 2007-08-01 |
| Determining Responses to Two Different Vaccines in HIV and HCV Infected Individuals (NCT00393276) | National Institute of Allergy and Infectious Diseases (NIAID) | 2007-08-01 |
| Transdermal Basal Insulin Patch Study in Type 1 Diabetes (NCT00519623) | Altea Therapeutics | 2007-08-01 |
| Study to Test Safety, Tolerability and Blood Levels of GSK971086 After 1 Dose & 7 Days of Dosing in Healthy Adult Males (NCT00540553) | GlaxoSmithKline | 2007-08-01 |
| Adoptive Transfer of MART1/Melan-A CTL for Malignant Melanoma (NCT00512889) | Dana-Farber Cancer Institute | 2007-08-01 |
| Radioimmunotherapy in Prostate Cancer Using 177Lu-J591 Antibody (NCT00538668) | Weill Medical College of Cornell University | 2007-08-01 |
| Chemotherapy Followed by Infusion of DMF5 Cells to Treat Metastatic Melanoma (NCT00924001) | National Cancer Institute (NCI) | 2007-08-01 |
| Proleukin and Rapamune in Type 1 Diabetes (NCT00525889) | National Institute of Allergy and Infectious Diseases (NIAID) | 2007-08-01 |
| Pharmacokinetics (PK) and Pharmacodynamics (PD) of Mayne Glucagon for Injection Compared With Glucagen® (Novo Nordisk) in Healthy Volunteers (NCT00745186) | Hospira, now a wholly owned subsidiary of Pfizer | 2007-08-01 |
| A Single-Dose Study of MK6349 in Patients With Type 2 Diabetes (6349-002) (NCT00943371) | Merck Sharp & Dohme LLC | 2007-08-01 |
| Cloretazine (VNP40101M) With Hematopoietic Cell Transplantation for Hematologic Malignancies (NCT00521859) | M.D. Anderson Cancer Center | 2007-08-01 |
| Phase 1 Study of Terameprocol (EM-1421) in Patients With Leukemia (NCT00664677) | Erimos Pharmaceuticals | 2007-08-01 |
| A Study to Determine the Fasting Bioequivalence of Reformulated OXY Tablets and Original OxyContin® (OXY) Tablets (NCT01101191) | Purdue Pharma LP | 2007-08-01 |
| A Study of Gastric Delay in Migraine Patients (3207-003) (NCT00548353) | Merck Sharp & Dohme LLC | 2007-08-01 |
| Fenretinide Lym-X-Sorb™ in Treating Patients With Recurrent or Resistant Solid Tumors or Lymphoma (NCT00589381) | National Institutes of Health Clinical Center (CC) | 2007-08-01 |
| Safety Study of ISIS 325568 in Healthy Volunteers (NCT00519727) | Ionis Pharmaceuticals, Inc. | 2007-08-01 |
| Improving Medication Adherence in Post-ACS Patients (NCT00576160) | Columbia University | 2007-08-01 |
| Safety and Tolerability Study of SNS-314 for Advanced Solid Tumors (NCT00519662) | Sunesis Pharmaceuticals | 2007-08-01 |
| Study to Determine the Maximum Tolerated Dose, Safety and Effectiveness of Pomalidomide for Patients With Sickle Cell Disease (NCT01522547) | Celgene | 2007-08-01 |
| Study of Pralatrexate in Patients With Relapsed or Refractory Cutaneous T-cell Lymphoma (NCT00554827) | Acrotech Biopharma Inc. | 2007-08-01 |
| Study Comparing Bioavailability of Oral Formulations of Vabicaserin (NCT00541996) | Wyeth is now a wholly owned subsidiary of Pfizer | 2007-08-01 |
| BOLD Functional Magnetic Resonance Imaging (fMRI) and Cerebral Blood Flow Measurements as Biomarkers for Cognition Enhancing Drugs (3134-006) (NCT00887601) | Merck Sharp & Dohme LLC | 2007-08-01 |
| Drug - Drug Interaction Study Between Quinine Sulfate and Theophylline (NCT00779259) | Mutual Pharmaceutical Company, Inc. | 2007-08-01 |
| Dose-Escalating Multiple Dose Study of PD-0360324 in Combination With Methotrexate in Patients With Rheumatoid Arthritis (NCT00550355) | Pfizer | 2007-08-01 |
| The Effect of Femoral Nerve Block on Opioid Requirements After Surgery for a Femur Fracture in Children (NCT00175591) | University of British Columbia | 2007-08-01 |
| Trial of Donor T Cells Sensitized With Pentadecapeptides of the CMV-PP65 Protein for the Treatment of Cytomegalovirus (CMV) Infections Following Allogeneic Hematopoietic Stem Cell Transplants (NCT00674648) | Memorial Sloan Kettering Cancer Center | 2007-08-01 |
| A Pharmacokinetic Study of Colchicine With an Oral Contraceptive (NCT01040845) | Mutual Pharmaceutical Company, Inc. | 2007-08-01 |
| Safety Study of PRLX 93936 in Patients With Advanced Solid Tumors (NCT00528047) | Prolexys Pharmaceuticals | 2007-08-01 |
| Study Evaluating the Bioequivalence of Levonorgestrel/Ethinyl Estradiol Combinations in Cycling Women (NCT00447863) | Wyeth is now a wholly owned subsidiary of Pfizer | 2007-08-01 |
| Evaluation of Pain Reduction in the Administration of Saline Injections by the Usage of Pneumatic Skin Flattening (NCT00503087) | PalJect Ltd. | 2007-08-01 |
| A Safety Study of XL019 in Adults With Myelofibrosis (NCT00522574) | Exelixis | 2007-08-01 |
| Anti-MAG First Administration to Human (NCT00622609) | GlaxoSmithKline | 2007-08-01 |
| Fructose-Induced Palmitate Synthesis in Overweight Subjects (NCT00535535) | Rockefeller University | 2007-08-01 |
| Study Evaluating a Combined Administration of Lecozotan SR and Citalopram in Young Healthy Subjects (NCT00538889) | Wyeth is now a wholly owned subsidiary of Pfizer | 2007-08-01 |
| Phase I Study of Gimatecan in Patients With Myelodysplastic Syndromes (NCT00493571) | M.D. Anderson Cancer Center | 2007-08-01 |
| A Study to Examine the Effect of Particle Size on Bioequivalence and Bioavailability (NCT00517543) | GlaxoSmithKline | 2007-08-01 |
| A Study to Test V930/V932 in Patients With Cancers Expressing Human Epidermal Growth Factor Receptor 2 (HER-2) and/or Carcinoembryonic Antigen (CEA)(V930-003)(COMPLETED) (NCT00647114) | Merck Sharp & Dohme LLC | 2007-08-01 |
| Phase 1b Study of Omega DUROS® in Patients With Chronic Hepatitis C Who Relapsed After Prior Treatment (NCT00519792) | Intarcia Therapeutics | 2007-08-01 |
| An Open Label Study to Assess the Effect of BLI800 on Safety and Clinical Chemistry Parameters (NCT00583713) | Braintree Laboratories | 2007-08-01 |
| PH I SRC Kinase, Dasatinib Combo Paclitaxel & Carboplatin in Pts w Ovarian, Peritoneal, & Tubal Cancer (NCT00672295) | AA Secord | 2007-08-01 |
| Topical Myristyl Nicotinate Cream on the Skin of Healthy Volunteers (NCT00619060) | University of Arizona | 2007-08-01 |
| An Open-Label Study of the Safety and Pharmacokinetics of Repeated-Dose Micafungin in Neonates (NCT00818584) | Astellas Pharma Inc | 2007-08-01 |
| Single Dose, Single Administration Study of Technosphere Inhalation Powder in Diabetic Subjects With Mild or Moderate Kidney Disease Compared to Diabetic Subjects With Normal Kidney Function (NCT00626249) | Mannkind Corporation | 2007-08-01 |
| Efficacy and Safety of Subcutaneous Versus Intravenous ACZ885 in Adult Patients With Established Rheumatoid Arthritis (NCT00505089) | Novartis | 2007-08-01 |
| Study of SGN-40, Lenalidomide, and Dexamethasone in Patients With Multiple Myeloma (NCT00525447) | Seagen Inc. | 2007-08-01 |
| A Study to Evaluate the Use of a Graded Infusion of Intravenous Glucose in the Assessment of Insulin Secretion Rates (MK-0000-078) (NCT01021462) | Merck Sharp & Dohme LLC | 2007-08-01 |
| Safety Study of CAT-8015 Immunoxin in Patients With NHL With Advance Disease (NCT00515892) | Cambridge Antibody Technology | 2007-08-01 |
| A Dose Escalation and Safety Study of I5NP in Patients Undergoing Major Cardiovascular Surgery (NCT00554359) | Quark Pharmaceuticals | 2007-08-01 |
| The Study To Test The Effect of Standardization Of Fluid Intake In Female Patients With Overactive Bladder (NCT00553657) | GlaxoSmithKline | 2007-08-01 |
| Genetically Engineered Lymphocytes, Cyclophosphamide, and Aldesleukin in Treating Patients With Relapsed or Refractory Mantle Cell Lymphoma or Indolent B-Cell Non-Hodgkin Lymphoma (NCT00621452) | Fred Hutchinson Cancer Center | 2007-08-01 |
| A Study to Evaluate the Effects of SB-751689 or rhPTH(1-34) on Excretion of Calcium and Phosphate in Women (NCT00532077) | GlaxoSmithKline | 2007-08-01 |
| Comparison of Two Forms of Hydrocortisone in Patients With Congenital Adrenal Hyperplasia (NCT00519818) | Neurocrine UK Limited | 2007-08-01 |
| A Phase I Study of CCI-779 (Temsirolimus) in Combination With Topotecan in Patients With Gynecologic Malignancies (NCT00523432) | University of Chicago | 2007-08-01 |
| Message Framing for Telephone Quitline Callers (NCT00589277) | Yale University | 2007-08-01 |
| Study of TRU-015 in Subjects With Membranous Nephropathy Secondary to Systemic Lupus Erythematosus (NCT00479622) | Wyeth is now a wholly owned subsidiary of Pfizer | 2007-08-01 |
| Trial of Docetaxel, Cisplatin, Fluorouracil (5-FU) for Unresectable Advanced Esophageal Squamous Cell Carcinoma (ESCC) (NCT00915850) | Wakayama Medical University | 2007-08-01 |
| An Exploratory Biomarker Study of ARQ 501 in Patients With Advanced Solid Tumors (NCT00524524) | ArQule, Inc., a subsidiary of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc. (Rahway, NJ USA) | 2007-08-01 |
| A/H5N1 Dose Ranging Study With Adjuvant Patch (NCT00532792) | Intercell USA, Inc. | 2007-08-01 |
| Trial of Montelukast in Eosinophilic Esophagitis (NCT00511316) | Mayo Clinic | 2007-08-01 |
| Comparing Fluoroscopy and Technological Methods for Guidance During Endovascular Procedures (NCT00355940) | Norwegian University of Science and Technology | 2007-08-01 |
| Secondary Primary Tumor Prevention With EGFR, OSI-774, and Cyclooxygenase-2 (NCT00400374) | Emory University | 2007-08-01 |
| Pandemic Influenza Plasmid DNA Vaccines (Needle-Free) (NCT00694213) | Vical | 2007-08-01 |
| Safety and Tolerability of the Twice Daily Intra-anal Application of NRL001 Cream for 14 Days (NCT06593730) | Norgine | 2007-08-01 |
| Safety Study of XL999 in Adults With Non-Small-Cell Lung Cancer (NCT00491699) | Symphony Evolution, Inc. | 2007-08-01 |
| The Pharmacokinetics and Safety Characteristics of Docetaxel in Patients With Cancer (NCT01268163) | Hospira, now a wholly owned subsidiary of Pfizer | 2007-08-01 |
| R(+)PPX High Dose Treatment of ALS (NCT00600873) | Bennett, James P., Jr., M.D., Ph.D. | 2007-08-01 |
| Continuous Administration of Oral Contraceptive, Primary Dysmenorrhea (NCT00517556) | Milton S. Hershey Medical Center | 2007-08-01 |
| Effects of Steady State Tipranavir/Ritonavir or Darunavir/Ritonavir or Ritonavir on Platelet Function, Coagulation and Fibrinolysis Biomarkers in Healthy Subjects (NCT02251795) | Boehringer Ingelheim | 2007-08-01 |
| A Randomized Controlled Clinical Trial With Orphans and Widows Who Experienced the Rwandan Genocide (NCT00553956) | University of Konstanz | 2007-08-01 |
| A Study to Investigate the Absorption, Metabolism, and Excretion of Canagliflozin (JNJ-28431754) in Healthy Male Volunteers (NCT01791231) | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 2007-08-01 |
| Comparison of Pharmacodynamics and Pharmacokinetics of Biphasic Insulin Aspart 30 and Insulin Glargine and Insulin Glulisine Therapy in Subjects With Type 2 Diabetes (NCT00824668) | Novo Nordisk A/S | 2007-08-01 |
| A Study of the Safety and Pharmacology of MetMAb (PRO143966), a Monovalent Antagonist Antibody to the Receptor C-Met, Administered Intravenously in Patients With Locally Advanced or Metastatic Solid Tumors (NCT01068977) | Genentech, Inc. | 2007-08-01 |
| A Trial to Evaluate the Safety of a Single Intravenous Infusion of MGAWN1 in Healthy Adults (NCT00515385) | MacroGenics | 2007-08-01 |
| NI-0401 in Patients With Acute Renal Allograft Rejection (NCT00805909) | Light Chain Bioscience - Novimmune SA | 2007-08-01 |
| Evaluation of [123I] AV94 and SPECT in Subjects With Alzheimer Disease in Comparison to Healthy Subjects (NCT00605059) | Institute for Neurodegenerative Disorders | 2007-08-01 |